PetMed Express Faces Nasdaq Filing Compliance Notice
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Petmed Express ( (PETS) ) just unveiled an update.
PetMed Express, Inc. announced on July 3, 2025, that it received a notice from Nasdaq due to a delay in filing its Annual Report on Form 10-K for the fiscal year ending March 31, 2025. This notice indicates non-compliance with Nasdaq’s timely filing requirements, but it does not immediately affect the company’s stock listing or trading. PetMed Express is required to submit a compliance plan by September 1, 2025, and may be granted an extension until December 29, 2025, to file the report. The company is actively working to complete its financial statements to regain compliance.
The most recent analyst rating on (PETS) stock is a Sell with a $3.50 price target. To see the full list of analyst forecasts on Petmed Express stock, see the PETS Stock Forecast page.
Spark’s Take on PETS Stock
According to Spark, TipRanks’ AI Analyst, PETS is a Neutral.
Petmed Express shows a mixed financial performance with strong balance sheet stability but weak profitability and inconsistent cash flow. Technical analysis indicates a bearish trend with oversold conditions, while valuation metrics suggest the stock may be overvalued. The earnings call highlights progress in profitability and strategic investments, but challenges remain in sales and competitive pressures. Overall, the stock score reflects these combined factors, indicating moderate potential with significant risks.
To see Spark’s full report on PETS stock, click here.
More about Petmed Express
Founded in 1996, PetMed Express, Inc., known as PetMeds, is a leading player in the direct-to-consumer pet healthcare sector. The company operates as a national online pharmacy licensed across all 50 states, offering a wide range of pet health solutions including pharmaceuticals, compounded medications, and OTC supplements. PetMeds focuses on providing value, convenience, and care to pet owners, enabling them to support the health and wellness of their pets.
Average Trading Volume: 143,075
Technical Sentiment Signal: Sell
Current Market Cap: $67.55M
Learn more about PETS stock on TipRanks’ Stock Analysis page.
